Vactosertib and Durvalumab in Gastric Cancer
NCT04893252
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
55
Enrollment
OTHER_GOV
Sponsor class
Conditions
Stomach Neoplasm
Interventions
DRUG:
durvalumab and vactosertib
Sponsor
Hark Kyun Kim